Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 181 to 185 of 185 entries
Sorted by: Best Match Show Resources per page
Outcomes related to anticoagulation management for mechanical valve replacements.

Journal of thoracic disease

Huckaby LV, Seese LM, Gleason TG, Sultan I, Wang Y, Thoma F, Kilic A.
PMID: 34164179
J Thorac Dis. 2021 May;13(5):2874-2884. doi: 10.21037/jtd-20-2562.

BACKGROUND: This study evaluates anticoagulation management and its impact on longitudinal clinical outcomes in patients undergoing mechanical valve replacement.METHODS: Patients undergoing mechanical mitral valve replacement (MVR) or aortic valve replacement (AVR) from 2010-2018 at a single center were included....

Cite
Huckaby LV, Seese LM, Gleason TG, et al. Outcomes related to anticoagulation management for mechanical valve replacements. J Thorac Dis. 2021;13(5):2874-2884doi: 10.21037/jtd-20-2562.
Huckaby, L. V., Seese, L. M., Gleason, T. G., Sultan, I., Wang, Y., Thoma, F., & Kilic, A. (2021). Outcomes related to anticoagulation management for mechanical valve replacements. Journal of thoracic disease, 13(5), 2874-2884. https://doi.org/10.21037/jtd-20-2562
Huckaby, Lauren V, et al. "Outcomes related to anticoagulation management for mechanical valve replacements." Journal of thoracic disease vol. 13,5 (2021): 2874-2884. doi: https://doi.org/10.21037/jtd-20-2562
Huckaby LV, Seese LM, Gleason TG, Sultan I, Wang Y, Thoma F, Kilic A. Outcomes related to anticoagulation management for mechanical valve replacements. J Thorac Dis. 2021 May;13(5):2874-2884. doi: 10.21037/jtd-20-2562. PMID: 34164179; PMCID: PMC8182532.
Copy Download .nbib Format: NLM
Methodological recommendations for assessing scleractinian and octocoral recruitment to settlement tiles.

PeerJ

Harper LM, Huebner LK, O'Cain ED, Ruzicka R, Gleason DF, Fogarty ND.
PMID: 35003917
PeerJ. 2021 Dec 17;9:e12549. doi: 10.7717/peerj.12549. eCollection 2021.

Quantifying recruitment of corals is important for evaluating their capacity to recover after disturbances through natural processes, yet measuring recruitment rates

Cite
Harper LM, Huebner LK, O'Cain ED, et al. Methodological recommendations for assessing scleractinian and octocoral recruitment to settlement tiles. PeerJ. 2021;9:e12549doi: 10.7717/peerj.12549.
Harper, L. M., Huebner, L. K., O'Cain, E. D., Ruzicka, R., Gleason, D. F., & Fogarty, N. D. (2021). Methodological recommendations for assessing scleractinian and octocoral recruitment to settlement tiles. PeerJ, 9e12549. https://doi.org/10.7717/peerj.12549
Harper, Leah M, et al. "Methodological recommendations for assessing scleractinian and octocoral recruitment to settlement tiles." PeerJ vol. 9 (2021): e12549. doi: https://doi.org/10.7717/peerj.12549
Harper LM, Huebner LK, O'Cain ED, Ruzicka R, Gleason DF, Fogarty ND. Methodological recommendations for assessing scleractinian and octocoral recruitment to settlement tiles. PeerJ. 2021 Dec 17;9:e12549. doi: 10.7717/peerj.12549. eCollection 2021. PMID: 35003917; PMCID: PMC8686733.
Copy Download .nbib Format: NLM
Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know.

Alzheimer's & dementia (Amsterdam, Netherlands)

Erickson CM, Chin NA, Johnson SC, Gleason CE, Clark LR.
PMID: 33665341
Alzheimers Dement (Amst). 2021 Feb 20;13(1):e12150. doi: 10.1002/dad2.12150. eCollection 2021.

Disclosure of personal disease-related information to asymptomatic adults has been debated over the last century in medicine and research. Recently, Alzheimer's disease (AD) has been conceptualized as a continuum that begins with a "preclinical" stage in which biomarkers are...

Cite
Erickson CM, Chin NA, Johnson SC, et al. Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know. Alzheimers Dement (Amst). 2021;13(1):e12150doi: 10.1002/dad2.12150.
Erickson, C. M., Chin, N. A., Johnson, S. C., Gleason, C. E., & Clark, L. R. (2021). Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know. Alzheimer's & dementia (Amsterdam, Netherlands), 13(1), e12150. https://doi.org/10.1002/dad2.12150
Erickson, Claire M, et al. "Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 13,1 (2021): e12150. doi: https://doi.org/10.1002/dad2.12150
Erickson CM, Chin NA, Johnson SC, Gleason CE, Clark LR. Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know. Alzheimers Dement (Amst). 2021 Feb 20;13(1):e12150. doi: 10.1002/dad2.12150. eCollection 2021. PMID: 33665341; PMCID: PMC7896633.
Copy Download .nbib Format: NLM
Recent changes to Arctic river discharge.

Nature communications

Feng D, Gleason CJ, Lin P, Yang X, Pan M, Ishitsuka Y.
PMID: 34824255
Nat Commun. 2021 Nov 25;12(1):6917. doi: 10.1038/s41467-021-27228-1.

Arctic rivers drain ~15% of the global land surface and significantly influence local communities and economies, freshwater and marine ecosystems, and global climate. However, trusted and public knowledge of pan-Arctic rivers is inadequate, especially for small rivers and across...

Cite
Feng D, Gleason CJ, Lin P, et al. Recent changes to Arctic river discharge. Nat Commun. 2021;12(1):6917doi: 10.1038/s41467-021-27228-1.
Feng, D., Gleason, C. J., Lin, P., Yang, X., Pan, M., & Ishitsuka, Y. (2021). Recent changes to Arctic river discharge. Nature communications, 12(1), 6917. https://doi.org/10.1038/s41467-021-27228-1
Feng, Dongmei, et al. "Recent changes to Arctic river discharge." Nature communications vol. 12,1 (2021): 6917. doi: https://doi.org/10.1038/s41467-021-27228-1
Feng D, Gleason CJ, Lin P, Yang X, Pan M, Ishitsuka Y. Recent changes to Arctic river discharge. Nat Commun. 2021 Nov 25;12(1):6917. doi: 10.1038/s41467-021-27228-1. PMID: 34824255; PMCID: PMC8617260.
Copy Download .nbib Format: NLM
From Blocking Shots to Blocking GI Transit, This Professional Basketball Player Does It All: A Case Report on Small Bowel Obstruction.

Case reports in medicine

DeMaio EL, Jarvis RC, Cohen JA, Gleason CN.
PMID: 33868406
Case Rep Med. 2021 Apr 01;2021:5534945. doi: 10.1155/2021/5534945. eCollection 2021.

Small bowel obstructions (SBO) are a commonly encountered diagnosis within emergency departments. Typically, these patients have evident risk factors including, but not limited to, prior abdominal surgery, personal or family history of gastrointestinal disorders, femoral and inguinal hernias, or...

Cite
DeMaio EL, Jarvis RC, Cohen JA, et al. From Blocking Shots to Blocking GI Transit, This Professional Basketball Player Does It All: A Case Report on Small Bowel Obstruction. Case Rep Med. 2021;2021:5534945doi: 10.1155/2021/5534945.
DeMaio, E. L., Jarvis, R. C., Cohen, J. A., & Gleason, C. N. (2021). From Blocking Shots to Blocking GI Transit, This Professional Basketball Player Does It All: A Case Report on Small Bowel Obstruction. Case reports in medicine, 20215534945. https://doi.org/10.1155/2021/5534945
DeMaio, Emily L, et al. "From Blocking Shots to Blocking GI Transit, This Professional Basketball Player Does It All: A Case Report on Small Bowel Obstruction." Case reports in medicine vol. 2021 (2021): 5534945. doi: https://doi.org/10.1155/2021/5534945
DeMaio EL, Jarvis RC, Cohen JA, Gleason CN. From Blocking Shots to Blocking GI Transit, This Professional Basketball Player Does It All: A Case Report on Small Bowel Obstruction. Case Rep Med. 2021 Apr 01;2021:5534945. doi: 10.1155/2021/5534945. eCollection 2021. PMID: 33868406; PMCID: PMC8035025.
Copy Download .nbib Format: NLM
Showing 181 to 185 of 185 entries